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Comparison of modern open infrarenal and
pararenal abdominal aortic aneurysm repair on
early outcomes and renal dysfunction at one year
Geetha Jeyabalan, MD,a Taeyoung Park, PhD,b Robert Y. Rhee, MD,a Michel S. Makaroun, MD,a and
Jae-Sung Cho, MD,a Pittsburgh, Pa; and Seoul, Korea
Objective:This study was conducted to review contemporary results of elective open infrarenal abdominal aortic aneurysm
(IAAA) and pararenal abdominal aortic aneurysm (PAAA) repairs and determine predictors of death and acute and 1-year
renal dysfunction (RD).
Methods: A retrospective review identified 432 consecutive patients undergoing open IAAA (233 patients) or PAAA (184
patients) repair between January 2000 and December 2007. Demographic, preoperative, intraoperative, and postoper-
ative variables were collected. RD was defined as an increase in creatinine of>0.5 mg/dL from baseline. Multiple logistic
regression models were used to identify predictors of mortality and RD.
Results: Mortality rates were similar between the groups (3.9% IAAA and 6.0% PAAA). Preoperative coronary artery
disease (CAD), postoperative myocardial infarction, or pulmonary complications were all strong predictors of operative
mortality in patients undergoing repair of PAAAs and IAAAs. However, neither PAAA nor baseline renal insufficiency
was an independent predictor of death. Postoperative RD occurred in 32% of patients after PAAA repairs compared with
13% of patients after IAAA repairs (P < .001). The presence of PAAA, baseline hypertension, and hyperlipidemia all
correlated positively with postoperative RD, while a trend was noted with baseline renal insufficiency (P  .09). At the
1-year follow-up, 5.1% of patients in the PAAA group had RD compared with none in the IAAA group. Similarly, the
serum creatinine level was significantly higher in the PAAA group (1.4 mg/dL vs 1.2 mg/dL, PAAA and IAAA,
respectively; P .02) at 1 year. However, there were no instances of new-onset hemodialysis dependence at 1 year. Mean
follow-up was 2.2 years overall.
Conclusion: Open PAAA repair can be performed without a significant increase in mortality compared to open IAAA
repair. Although the incidence of renal function deterioration after open PAAA repairs remains higher than with open
IAAA repairs, the overall incidence remains low at 1-year follow-up. (J Vasc Surg 2011;54:654-9.)
i
a
t
T
r
w
a
M
p
p
r
a
r
n
b
w
l
i
r
o
o
p
pWith over 60% of infrarenal abdominal aortic aneurysm
(IAAA) repairs being candidates for repair using endovas-
cular techniques,1 a greater proportion of open aneurysm
repair is being performed on complex juxtarenal abdominal
aortic aneurysms (JAAAs) and pararenal abdominal aortic
aneurysms (PAAAs).2 As midterm results after endovascu-
lar repair of these anatomically challenging aneurysms
emerge,3-5 it is essential that results after open repair be
reviewed contemporaneously as the “gold standard.” Al-
though cardiopulmonary complications and visceral isch-
emia remain significant postoperative complications after
PAAA repair, several large institutional retrospective series
published over the last decade have focused on acute renal
dysfunction (RD) as the primary perioperative morbid-
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654ty.6-9 Although these series have described early perioper-
tive renal outcomes after open repair, few examine the rela-
ionship between open PAAA repair and late renal outcomes.
he purpose of this review was to compare contemporary
esults after open PAAA repair vs IAAA repair. Furthermore,
e sought to identify key predictors of mortality in addition to
cute and late RD after open PAAA repair.
ETHODS
A retrospective chart review identified 432 consecutive
atients undergoing open IAAA or PAAA repair over a
eriod spanning January 2000 and December 2007. Para-
enal aneurysm is defined as aneurysms that have no normal
orta between the upper extent of the aneurysm and the
enal arteries. It can be classified into juxtarenal or suprare-
al types. JAAA includes aneurysms that extend to just
elow the renal arteries without involving the renal arteries,
hereas a suprarenal AAA includes that which involves at
east one renal artery orifice.10
A total of 15 patients were excluded from the analysis,
ncluding six patients who did not have adequate medical
ecords available and nine patients who did not have pre-
perative baseline serum creatinine values. This left a total
f 233 patients who underwent IAAA repair and 184
atients who underwent PAAA (157 JAAAs and 27 su-
rarenal AAAs) that form the basis for this study. IAAA
epairs were those in which the aortic cross-clamp was
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Volume 54, Number 3 Jeyabalan et al 655intended to be placed in an infrarenal location and the graft
sewn to the infrarenal aorta. PAAA repairs were those in
which aortic control was planned to be proximal to at least
one renal artery. The reasons for this classification are as
follows. First, it was not the purpose of this study to
investigate the effects of clamp location on subsequent
renal function, but to see the natural history of renal
function per the type of aneurysm after its open repair,
regardless of aortic cross-clamp location. Second, aortic
cross-clamp site does not necessarily correlate with or rep-
resent the extent of aneurysmal disease; a surgeon may
preferentially place a supraceliac clamp rather than suprare-
nal clamp even when there is a suitable suprarenal aorta for
clamping, whereas another surgeon may dissect and clamp
the supra-superior mesenteric artery (SMA) aorta to avoid
unnecessary hepatic ischemia from supraceliac clamping.
Baseline variables, including demographic data, pre-
existing RD, dialysis dependence, cardiopulmonary disease,
hyperlipidemia, statin and tobacco use, and AAA size were
recorded. Intraoperative data gathered included clamp loca-
tion, aneurysm type, renal vein division, renal artery recon-
struction, visceral and renal ischemia time, and type of repair.
Postoperative variables examined included in-hospital mor-
tality, cardiopulmonary complications, bleeding, paraple-
gia, visceral ischemia, and RD. Renal function at 1 year was
also analyzed for patients who had available data, which
included 121 patients in the IAAA repair group and 79
patients in the PAAA group. Baseline RD was defined as a
serum creatinine 1.5 mg/dL. RD was defined as a creat-
inine increase0.5 mg/dL during the hospitalization or at
1-year follow-up. Hemodialysis dependence preopera-
tively, postoperatively, and at the 1-year time point was also
noted.
Statistical analysis. The 2 or Fisher exact tests were
performed for categorical variables. Analysis of variance was
used for continuous variables. The proportion of missing
data was generally low (less than 1%), and patients with
missing data were eliminated from the analysis. Baseline
characteristic, comorbidities, and operative variables de-
tailed in Tables I to IV were entered into univariate analysis.
Logistic regression models were used to determine predic-
tors of selected outcomes and used to calculate odds ratios.
Independent variables that were correlated with one an-
other were excluded from the regression models. The R
statistical software (version 2.11.0; http://www.r-project.
org) was used. This study was approved by the Institutional
Review Board of the University of Pittsburgh.
RESULTS
There were no differences in the number of annual
IAAA or PAAA repairs done during the study period. There
were 14 surgeons who performed both procedures at the
University of Pittsburgh Medical Center with a wide vari-
ation in the number of cases among them ranging from one
to 172 cases. No differences in outcomes were noted per
surgeons’ volume.
Patient demographics and baseline characteristics are
detailed in Table I. Patients who underwent PAAAs were older and had a higher incidence of coronary artery disease
CAD) and baseline renal insufficiency.
Operative variables. Tables II and III illustrate intra-
perative variables analyzed. As noted in Table II, the
ajority of PAAA repairs had suprarenal aortic control.
upraceliac aortic control was obtained in 18% of all pa-
ients with PAAAs, some of which were moved from an
riginal suprarenal location due to intraoperative technical
ariables. Seven patients undergoing IAAA repair also re-
uired suprarenal clamping due to difficulty with either
emorrhage or quality of the aorta at the infrarenal level (ie,
alcification). A significantly higher proportion of the pa-
ients with PAAAs underwent left renal vein division intra-
able I. Patient demographics and baseline
haracteristics
ariables
Infrarenal
n  233 (%)
Pararenal
n  184 (%)
P
value
ean age 70.5 73.2 .001
ale 171 (73.4) 123 (66.8) .18
AD 116 (49.8) 116 (63) .009
TN 183 (78.5) 152 (82.6) .36
moking 96 (41.2) 70 (56.9) .56
yperlipidemia 128 (54.9) 107 (58.1) .58
tatin use 117 (50.2) 87 (47.2) .62
ean AAA size 6.15 cm 6.02 cm .28
ialysis 4 (1.7) 1 (0.5) .39
ean preoperative Cr 1.18 mg/dL 1.27 .19
r preoperative 1.5
mg/dL 21 (9) 31 (16.8) .02
AA, Abdominal aortic aneurysm; CAD, coronary artery disease; Cr,
reatinine; HTN, hypertension.
able II. Intraoperative variables: aortic cross-clamp site
nd renal vein division
ariables
Infrarenal
n  233 (%)
Pararenal
n  184 (%)
ortic cross-clamp site
Infrarenal 225 (97) 0 (0)
Interrenal 3 (1.3) 44 (23.9)
Suprarenal 1 (0.4) 102 (55.4)
Supra-SMA 0 (0) 3 (1.6)
Supraceliac 3 (1.3) 33 (17.9)
enal vein division 3 (1.3) 17 (9.2)
MA, Superior mesenteric artery.
able III. Renal artery reconstruction
ariables
Infrarenal
n  233 (%)
Pararenal
n  184 (%)
enal endarterectomy 0 4 (2.2)
enal artery reimplantation 0 6 (3.3)
enal artery bypass 0 8 (4.4)
ilateral bypass 0 2
nilateral bypass 0 6peratively compared with patients with IAAAs (9.2% vs
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September 2011656 Jeyabalan et al1.3%; P  .001); none of the divided renal veins was
reconstructed. The mean renal ischemic time for all who
had aortic cross-clamp above at least one renal artery was
29.7 minutes.
Concomitant renal artery reconstruction was per-
formed on 18 patients in the PAAA group (Table III). A
majority of patients (78%) underwent renal artery bypass or
reimplantation as opposed to renal endarterectomy. Use of
a cold perfusion solution consisting of heparin, mannitol,
furosemide, and bicarbonate was documented in 28 cases.
The initial dose of cold perfusate is 90 to 120 mL per each
kidney with an additional 60 mL to each kidney every 15
minutes. Systemic mannitol was used in all cases of suprare-
nal clamping. No ischemic preconditioning was used in this
series. The number of patients who received vasodilators
was too small; therefore, it was not included in the analysis.
Death and complications. Postoperative complica-
tions are detailed in Table IV. There were no significant
differences between the two groups with regard to opera-
tive deaths or complications, except for a higher incidence
of bleeding requiring re-exploration in the PAAA group.
Preoperative CAD, postoperative myocardial infarction, or
pulmonary complications were all strong predictors of op-
erative mortality in patients undergoing repair of PAAAs
and IAAAs (Table V). The presence of a PAAA, renal
ischemic time, renal vein division, or baseline renal insuffi-
ciency was an independent predictor of death.
Renal function. RD was examined in the postopera-
tive period and at 1-year follow-up. Approximately one-
third of all patients (32.1%) undergoing PAAA repairs
suffered postoperative RD, whereas only 13.3% of those
undergoing IAAA repairs did (P .001). Duration of renal
ischemic time was associated with RD. The mean renal
ischemic time was significantly higher in patients with RD
in the postoperative period (21.3 minutes vs 11.1 minutes;
P .001), and at 1 year (28.8 minutes vs 12.6 minutes; P
.001). Aortic cross-clamp site was also associated with
postoperative (P  .02) and 1-year (P  .03) RD (Table
VI): the more proximal the clamp site, the higher likelihood
Table IV. Postoperative complications
Infrarenal
n  233 (%)
Pararenal
n  184 (%)
P
value
Death 9/233 (3.9) 11/184 (6.0) .36
MI 10/233 (4.3) 15/184 (8.2) .14
Bowel ischemia 4/233 (1.7) 6/184 (3.3) .35
Pulmonary
complications 22/233 (9.4) 24/184 (13.0) .27
Paraplegia 1/233 (0.4) 0/184 (0) .99
CVA 3/233 (1.3) 3/184 (1.6) .99
Bleeding 1/233 (0.4) 8/184 (4.3) .01
Cr increase 0.5
mg/dL 31/228 (13.3) 59/183 (32.1) .001
HD postoperativea 2/228 (0.9) 5/183 (2.7) .25
Cr, Creatinine; CVA, cerebrovascular accident; HD, hemodialysis. MI,
myocardial infarction.
aExcluding those on HD preoperatively.of RD. Division of left renal vein was not predictive of RD. dExcluding those patients who were on hemodialysis pre-
peratively, only seven patients in this series developed renal
ailure requiring dialysis in the postoperative period. Five of
he seven patients with new-onset hemodialysis died within 1
ear of their operations. The other two patients died at 25 and
9 months postoperatively and were still dialysis dependent at
he time. Three of the 18 patients who had renal artery
econstruction had baseline renal insufficiency preopera-
ively and all three patients had improvement in their renal
unction to creatinine values of 1.5 mg/dL postopera-
ively. It is of note that two of the 18 patients without
aseline renal insufficiency had postoperative RD; one pa-
ient had sustained RD at the 1-year follow-up and the
ther was lost to follow-up. Renal revascularization was not
ssociated with RD or operative mortality rate. One-year
enal function data were only available for 10 of the 19
atients; all except for one of these patients had stable renal
unction at the 1-year time point. On logistic regression
nalysis, the presence of PAAA, large aneurysm size, base-
ine hypertension, and hyperlipidemia all correlated posi-
ively with the development of postoperative RD (Table
II). A trend toward postoperative RD was noted with
reoperative RD; this was statistically nonsignificant (P 
1). Interestingly, a protective trend toward postoperative
enal function was noted with the use of statins (P  .1).
At the 1-year follow-up, a significantly higher percent-
ge of patients in the PAAA group had sustained RD.
verall, 5.1% of patients in the PAAA group had a creati-
ine increase of0.5 mg/dL at 1 year, whereas none did in
he IAAA group (P  .02). Similarly, the serum creatinine
evel was significantly higher in the PAAA group (1.4
g/dL vs 1.2 mg/dL; PAAA and IAAA, respectively; P
02) at 1 year. However, there were no instances of new-
nset hemodialysis dependence at 1-year follow-up. Mean
ollow-up was 2.2 years overall.
ISCUSSION
This study shows that PAAA repairs are at increased risk
f postoperative RD compared with IAAA repairs but with
low incidence of new-onset hemodialysis. At 1-year
ollow-up, the mean creatinine remained elevated by a
able V. Predictors of in-hospital mortality by logistic
egression analysis
Odds ratio 95% CI P value
AAA 1.5 0.38-6.14 .56
reoperative Cr 1.5 2.0 0.32-12.23 .47
ale 0.3 0.1-1.1 .08
AD 4.6 1.1-34.2 .06
AOD 0.06 0.0-0.73 .03
ancer 0.03 0.0-0.71 .03
ostoperative MI 44.9 7.2-279 .001
ulmonary complications 115.6 18.2-734.8 .001
AD, Coronary artery disease; CI, confidence interval; Cr, creatinine; MI,
yocardial infarction; PAAA, pararenal abdominal aortic aneurysm; PAOD,
eripheral arterial occlusive disease.ifference of 0.2 mg/dL after PAAA repair without any
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clinical significance of this difference remains to be deter-
mined.
Acute RD after open repair of PAAA is a major source
of morbidity with reported incidence up to 39%.11 The
incidence of acute RD observed in the present study is
consistent with what has been reported previously in the
literature. However, it should be noted that comparison of
results in the literature is very difficult due to nonuniform
definitions and measures of RD and the proportion of
patients with baseline renal insufficiency. New-onset hemo-
dialysis in this series was comparable to recent pooled data
showing a median incidence of new-onset hemodialysis of
3.3% in patients undergoing JAAA repair.11 When these
patients do become dialysis-dependent, the mortality rate
increases significantly.3,12 The overall mortality rate noted
in the present series is also comparable to literature that
varies considerably from 0.8% to 6.3%.6-9,13
Because RD adversely impacts the patient’s quality of
life and life expectancy significantly,3,12,14 it is important to
delineate the extent of not only the early but also the late
renal outcome after repair of the PAAA. With the increasing
application of endovascular technology to the treatment of
PAAA with fenestrated/branched devices, it is necessary to
compare the late renal function between open and endovas-
cular repairs. Whereas an increased risk of late renal function
decline after endovascular aneurysm repair (EVAR) com-
pared with open repair for IAAAs has been well estab-
lished,15,16 the literature is scarce on late renal function
after these therapeutic modalities, let alone comparative
effects of the two.
AAAs have been linked to RD.17 This condition may
Table VI. Effects of aortic cross-clamp site on renal functi
Infrarenal Inter-rena
No postoperative RD 86.6% 77.1%
Postoperative RD 13.4% 22.9%
Sum 223 48
No 1-year RD 100% 100%
1-year RD 0% 0%
Sum 120 19
RD, Renal dysfunction; SMA, superior mesenteric artery.
Table VII. Predictors of postoperative renal dysfunction
by logistic regression analysis
Odds ratio 95% CI P value
PAAA 2.9 1.7-4.8 .001
Preoperative Cr 1.5 1.8 0.9-3.4 .1
AAA size 1.3 1.0-1.5 .02
HTN 2.5 1.2-5.4 .02
Hyperlipidemia 2.2 0.9-5.4 .07
Statin use 0.5 0.2-1.2 .1
AAA, Abdominal aortic aneurysm; CI, confidence interval; Cr, creatinine;
HTN, hypertension; PAAA, pararenal abdominal aortic aneurysm.continue to deteriorate after AAA repair whether by open er endovascular means. Factors that have been known to
ontribute to renal function decline after open repair in-
lude preoperative renal insufficiency, blood loss, hypoten-
ion, embolization from aortic cross-clamping, and renal
schemia; those after endovascular repair include wire ma-
ipulation, stent graft deployment, exposure to contrast
uring the procedure and follow-up, and branch vessel
tenosis/occlusion.3,6-9,12,18-20
The long-term effect of left renal division remains
ebatable.8,21,22 Although West et al8 found renal vein
ivision to be associated with pulmonary complications and
enal insufficiency, it was not associated with any RD or
eath in the present series. Every effort is made in our
nstitution to avoid left renal vein division if at all possible.
It is unknown whether late renal outcome is affected by
he method of repair. In a systematic review, Nordon et al4
oted a higher transient early renal failure rate after open
epair as compared with EVAR for PAAA. Verhoeven et al5
oted, at a mean follow-up of 2 years after EVAR for
AAA, that 25 of 100 patients in their series experienced a
30% rise in creatinine. It should be noted that branch
essel stenosis or occlusion accounted for the RD in only
ne patient. Haddad et al12 noted, at a mean follow-up of 6
onths, a 33% incidence of30% glomerular filtration rate
GFR) deterioration and a 24% incidence of renal-related
vents (stenosis, occlusion, hemodialysis), more commonly
bserved in patients with baseline renal insufficiency.
Late renal function outcome after open repair of PAAA
emains poorly defined.11 The present series is the first
ontemporary series of open PAAA repair that examines
enal outcomes beyond the postoperative period compared
ith an IAAA repair cohort. The overall incidence of RD at
year was low at 5.1% with no new onset of hemodialysis
ependence. In the present study, a trend without statisti-
al significance was noted between preoperative and post-
perative RD. It is possible that baseline renal insufficiency
as underestimated in our population. If estimated glo-
erular filtration rate (eGFR) had been used, a larger
ohort of patients would have qualified as having preoper-
tive renal insufficiency. This would have potentially re-
ulted in a stronger correlation between preoperative and
ostoperative RD.
It is paramount to identify and modify factors impact-
ng renal function decline. In the current study, the pres-
nce of PAAA, hypertension, and preoperative hyperlipid-
Suprarenal Supra-SMA Supraceliac
69.3% 0% 58.3%
30.7% 100% 41.7%
101 3 36
93=% 100% 93.8%
7% 0% 6.3%
43 2 16ons
lmia positively predicted postoperative RD, whereas statin
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preoperative control of modifiable factors may prevent
postoperative complications in this subset of patients. In-
traoperative adjuvant therapy such as use of cold renal
perfusion,23,24 renal vasodilators,25,26 and/or ischemic
preconditioning27 may also contribute to preservation of
renal function. Addition of steroids to the renal perfusion
solution has also been shown to be beneficial in an animal
model.28 It remains to be seen if the short-term benefits
achieved with these measures will lead to lasting effects.
Reconstruction of the renal arteries may help preserve
late renal function. Although all three of the patients with
baseline renal insufficiency experienced improvement in
their renal function after renal revascularization in this
series, the numbers are too small to draw a meaningful
conclusion. It should be noted, however, that renal revas-
cularization has been associated with higher mortality and
postoperative renal failure.6,29
The location of the aortic clamp during the repair may
also play a role in postoperative short-term and midterm
renal function, although there is no consensus in the liter-
ature. Some investigators found no association between
clamp site and postoperative RD,7,13 whereas others have
noted a positive correlation.6,9 The current series did not
find any correlation with aortic clamp site and postoperative
renal deterioration. This may be related to the small num-
ber of patients (18%) receiving a supraceliac clamp in this
series. The authors believe that the risk of embolization
from a diseased pararenal or paravisceral aorta remains a
realistic concern and advocate placement of an aortic clamp
on the nondiseased aorta. Supra-SMA aortic control can
also be a useful tool when suprarenal clamping is not ideal
and hepatic ischemia is to be avoided.
There is significant interest in the pleiotropic effects of
statins on vascular disease in both acute and chronic set-
tings. The modulation of anti-inflammatory pathways in
addition to the lipid-lowering properties of statins is only a
few of the mechanisms by which these ubiquitous drugs
play a role in vascular biology. A recent meta-analysis of
several cohort studies examining statin therapy on aortic
aneurysm expansion in addition to perioperative and long-
term mortality suggested that there was no significant
difference in 30-day mortality after AAA treatment in pa-
tients on statin therapy.30 However, all-cause postoperative
mortality at 1, 2, and 5 years was significantly improved in
patients on statins. Statin use seemed to have potentially
protective effects on renal function in this series, although
statistical significance was not achieved.
Limitations of the present study include the retrospec-
tive, nonrandomized design, although baseline character-
istics between the two groups were relatively similar. In
addition, a significant number of patients were lost to
follow-up. Using serum creatinine measurements instead of
eGFR is a less sensitive indicator of acute changes in renal
function. Ultimately, biomarkers that are more sensitive are
needed to accurately assess acute kidney injury. Until then,
there seems to be some consensus that in critically ill
patients, acute kidney injury scores should include a com-ination of serum creatinine changes and urine output.31
arge changes in serum creatinine are reflective of clinically
elevant RD. As previous studies have suggested, an accu-
ate estimation of GFR depends on a relatively steady state,
hich is unusual in a patient with acute postoperative
eterioration of renal function.15,32 An eGFR may overes-
imate true GFR in the face of an acutely rising serum
reatinine level. Ultimately, the definition of renal insuffi-
iency has been inconsistent throughout several studies
xamining this phenomenon post-PAAA repair. We sought
o use a definition that was concordant with the larger series
ver the past decade.7-9
ONCLUSIONS
Open PAAA repair can be performed without a signif-
cant increase in mortality compared with open IAAA re-
air. The development of postoperative hemodialysis de-
endence is associated with a high mortality rate. Although
he incidence of renal function deterioration after open
AAA repairs remains higher than with open IAAA repairs,
he overall incidence remains low at 1-year follow-up. A
rospective randomized trial comparing open and endovas-
ular repair of PAAAs will help determine the late renal
utcomes. Until then, these results may be used as a refer-
nce against which the results of EVAR for suprarenal and
uxtarenal AAAs using fenestrated devices could be com-
ared.
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